Peak6 Investments LLC Cytosorbents Corp Transaction History

Peak6 Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$3.61 - $5.22 $18,927 - $27,368	-5,243 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$4.33 - $7.63 $22,702 - $40,004	5,243 New	5,243 $26,000
Q4 2018 Feb 13, 2019	SELL	$7.05 - $12.64 $179,598 - $322,004	-25,475 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$10.95 - $14.8 $278,951 - $377,030	25,475 New	25,475 $329,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.